Autoimmune cholangitis in NOD.c3c4 mice is associated with cholangiocyte-specific Fas antigen deficiency

Journal of Autoimmunity

Volumn 29, Issue 1, 2007, Pages 20-29

  Nakagome, Yu ^a   Ueno, Yoshiyuki ^a   Kogure, Takayuki ^a   Fukushima, Koji ^a   Moritoki, Yuki ^a,b   Ridgway, William M ^c   Eric Gershwin, M ^b   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autoimmunity; Inflammation

Indexed keywords

CELL NUCLEUS ANTIGEN; FAS ANTIGEN; MITOCHONDRION ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BILE DUCT; BILE DUCT CYST; CELL PROLIFERATION; CHOLANGITIS; CONTROLLED STUDY; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; LIVER CELL; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MICROARRAY ANALYSIS; MOUSE; NICK END LABELING; NONHUMAN; NONOBESE DIABETIC MOUSE; PORTAL VEIN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; CELL PROLIFERATION; CHOLANGITIS; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; LIVER; MICE; MICE, INBRED NOD; MITOCHONDRIAL PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 34347339578     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.03.004     Document Type: Article

References (36)

1. Alpini G., McGill J.M., and Larusso N.F. The pathobiology of biliary epithelia. Hepatology 35 (2002) 1256-1268
2. Kaplan M.M., and Gershwin M.E. Primary biliary cirrhosis. N Engl J Med 353 (2005) 1261-1273
3. Gershwin M.E., and Mackay I.R. Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 100 (1991) 822-833
4. Gershwin M.E., Selmi C., Worman H.J., Gold E.B., Watnik M., Utts J., et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42 (2005) 1194-1202
5. Mackay I.R., and Gershwin M.E. The nature of autoimmune disease. Semin Liver Dis 17 (1997) 3-11
6. Gershwin M.E., Ansari A.A., Mackay I.R., Nakanuma Y., Nishio A., Rowley M.J., et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 174 (2000) 210-225
7. Koarada S., Wu Y., Fertig N., Sass D.A., Nalesnik M., Todd J.A., et al. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 173 (2004) 2315-2323
8. Irie J., Wu Y., Wicker L.S., Rainbow D., Nalesnik M.A., Hirsch R., et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 203 (2006) 1209-1219
9. Matsumura S., Van De Water J., Kita H., Coppel R.L., Tsuji T., Yamamoto K., et al. Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases. Hepatology 35 (2002) 14-22
10. Matsumura S., Van De Water J., Leung P., Odin J.A., Yamamoto K., Gores G.J., et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 39 (2004) 1415-1422
11. Odin J.A., Huebert R.C., Casciola-Rosen L., LaRusso N.F., and Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108 (2001) 223-232
12. Moritoki Y., Ueno Y., Kanno N., Yamagiwa Y., Fukushima K., Gershwin M.E., et al. Lack of evidence that bone marrow cells contribute to cholangiocyte repopulation during experimental cholestatic ductal hyperplasia. Liver Int 26 (2006) 457-466
13. Ueno Y., Ishii M., Yahagi K., Mano Y., Kisara N., Nakamura N., et al. Fas-mediated cholangiopathy in the murine model of graft versus host disease. Hepatology 31 (2000) 966-974
14. Ueno Y., Alpini G., Yahagi K., Kanno N., Moritoki Y., Fukushima K., et al. Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice. Liver Int 23 (2003) 449-459
15. Kodama Y., Hijikata M., Kageyama R., Shimotohno K., and Chiba T. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 127 (2004) 1775-1786
16. Fukushima K., Ueno Y., Inoue J., Kanno N., and Shimosegawa T. Filopodia formation via a specific Eph family member and PI3K in immortalized cholangiocytes. Am J Physiol Gastrointest Liver Physiol 291 (2006) G812-G819
17. Locke III G.R., Therneau T.M., Ludwig J., Dickson E.R., and Lindor K.D. Time course of histological progression in primary biliary cirrhosis. Hepatology 23 (1996) 52-56
18. Shackel N.A., McGuinness P.H., Abbott C.A., Gorrell M.D., and McCaughan G.W. Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis:cDNA array analysis of intrahepatic differential gene expression. Gut 49 (2001) 565-576
19. Ayres R.C., Hubscher S.G., Shaw J., Garner C., Joplin R., Williams A., et al. New monoclonal antibodies reacting with bile ducts: further insights into the pathogenesis of bile ductular proliferation in biliary diseases. J Pathol 165 (1991) 153-161
20. Ishii M., Vroman B., and LaRusso N.F. Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. Gastroenterology 97 (1989) 1236-1247
21. Joplin R., Hishida T., Tsubouchi H., Daikuhara Y., Ayres R., Neuberger J.M., et al. Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest 90 (1992) 1284-1289
22. Joplin R., Strain A.J., and Neuberger J.M. Immuno-isolation and culture of biliary epithelial cells from normal human liver. In Vitro Cell Dev Biol 25 (1989) 1189-1192
23. Joplin R., Strain A.J., and Neuberger J.M. Biliary epithelial cells from the liver of patients with primary biliary cirrhosis: isolation, characterization, and short-term culture. J Pathol 162 (1990) 255-260
24. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
25. Kawane K., Fukuyama H., Kondoh G., Takeda J., Ohsawa Y., Uchiyama Y., et al. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 292 (2001) 1546-1549
26. Sakai T., Kimura Y., Inagaki-Ohara K., Kusugami K., Lynch D.H., and Yoshikai Y. Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice. Gastroenterology 113 (1997) 168-174
27. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., et al. Lethal effect of the anti-Fas antibody in mice. Nature 364 (1993) 806-809
28. Hiramatsu N., Hayashi N., Katayama K., Mochizuki K., Kawanishi Y., Kasahara A., et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19 (1994) 1354-1359
29. Iwata M., Harada K., Hiramatsu K., Tsuneyama K., Kaneko S., Kobayashi K., et al. Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis. Liver 20 (2000) 129-135
30. Chen X.M., Gores G.J., Paya C.V., and LaRusso N.F. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol 277 (1999) G599-G608
31. Que F.G., Phan V.A., Phan V.H., Celli A., Batts K., LaRusso N.F., et al. Cholangiocarcinomas express Fas ligand and disable the Fas receptor. Hepatology 30 (1999) 1398-1404
32. Harada K., Furubo S., Ozaki S., Hiramatsu K., Sudo Y., and Nakanuma Y. Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis. J Hepatol 34 (2001) 500-506
33. Sasaki M., Ikeda H., Haga H., Manabe T., and Nakanuma Y. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss. J Pathol 205 (2005) 451-459
34. Tanaka A., Leung P.S., Kenny T.P., Au-Young J., Prindiville T., Coppel R.L., et al. Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis. J Autoimmun 17 (2001) 89-98
35. Wang A.P., Migita K., Ito M., Takii Y., Daikoku M., Yokoyama T., et al. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun 25 (2005) 85-91
36. Wakabayashi K., Lian Z.X., Moritoki Y., Lan R.Y., Tsuneyama K., Chuang Y.H., et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 44 (2006) 1240-1249